RaDCom

Radiotherapy-Drug Combinations Consortium (RaDCom)

The Radiotherapy-Drug Combinations Consortium (RaDCom) was established by CTRad and the Cancer Research UK (CRUK) Centre for Drug Development (CDD) in 2013. RaDCom is a collaborative network of UK-based laboratories working in partnership with industry, CRUK and other funding bodies; it seeks to work with UK-based investigators to develop and deliver high quality preclinical projects evaluating specific radiotherapy-drug combinations, to provide the necessary evidence base for early phase clinical trials.

For more information please visit their website.